Cannabis use in patients with Fibromyalgia: Effect on symptoms relief and health-related quality of life

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Fiz, Jimena ^a,b   Durán, Marta ^c   Capellà, Dolors ^b,c   Carbonell, Jordi ^d   Farré, Magí ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Fundacion Institut Catala de Farmacologia   (Spain)

^d Rheumatology Unit   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; CANNABIS; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CANNABIS SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIZZINESS; DRUG EFFECT; DRUG USE; EYE IRRITATION; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; HYPOTENSION; MALE; PAIN; PITTSBURGH SLEEP QUALITY INDEX; QUALITY OF LIFE; QUESTIONNAIRE; RIGIDITY; SCORING SYSTEM; SEDATION; SHORT FORM 36; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; VISUAL ANALOG SCALE; WELLBEING; XEROSTOMIA; MIDDLE AGED; PATHOPHYSIOLOGY;

CANNABIS;

ADULT; CANNABIS; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; QUALITY OF LIFE;

EID: 79955385056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018440     Document Type: Article

References (18)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160-172.
2. Abeles AM, Pillinger MH, Solitar BM, Abeles M, (2007) Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 146: 726-734.
3. Martinez-Lavin M, (2007) Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 9: 216.
4. Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR, (2007) Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 23: 17-24.
5. Pacher P, Bátkai S, Kunos G, (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389-462.
6. Schley M, Legler A, Skopp G, Schmelz M, Konrad C, et al. (2006) Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Curr Med Res Opin 22: 1269-1276.
7. Skrabek RQ, Galimova L, Ethansand Daryl K, (2008) Nabilone for the Treatment of Pain in Fibromyalgia. J Pain 9: 164-73.
8. Ware MA, Fitzcharles MA, Joseph L, Shir Y, (2010) The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg 110: 604-610.
9. Russo EB, (2008) Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 29: 192-200.
10. Alonso J, Prieto L, Antó JM, (1995) La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. Med Clin (Barc) 104: 771-776.
11. Rivera J, Gonzalez T, (2004) The Fibromyalgia Impact Questionnaire: A Validated Spanish version to asses the health status in women with fibromyalgia. Clin Exp Rheumatol 22: 554-560.
12. Royuela Rico A, Macías Fernández JA, (1997) Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg. Vigilia-Sueño 9: 81-94.
13. Lynch ME, Young J, Clark AJ, (2006) A case series of patients using medicinal marihuana for management of chronic pain under the Canadian Marihuana Medical Access Regulations. J Pain Symptom Manage 32: 497-501.
14. Blackburn-Munro G, (2004) Hypothalamo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Curr Pain Headache Rep 2004; 8: 116-24.
15. Buskila D, (2009) Developments in the scientific and clinical understanding of fibromyalgia. Arthritis Res Ther 11: 242.
16. Dadabhoy D, Clauw DJ, (2006) Therapy insight: fibromyalgia a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2: 364-372.
17. Carrier EJ, Patel S, Hillard CJ, (2005) Endocannabinoids in neuroimmunology and stress. Curr Drug Targets CNS Neurol Disord 4: 657-665.
18. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.